BioPharmX Cancels Presentation at Oppenheimer's 28th Annual Healthcare Conference Due to Severe Weather

Wednesday, March 21, 2018 Environmental Health
Email Print This Page Comment bookmark
Font : A-A+

MENLO PARK, Calif., March 20, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical

company developing dermatology products, today announces that it has cancelled its presentation at Oppenheimer's 28th Annual Healthcare Conference in New York tomorrow, due to the winter storm warnings forecasted
for the region.  BioPharmX President and Co-founder Anja Krammer had been scheduled to speak.

The corporate presentation may be downloaded from the Overview section of the company's Investors web page: http://biopharmx.investorroom.com.

About BioPharmX® Corporation BioPharmX Corporation (NYSE American: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter (OTC), and supplement applications in the health and wellness markets, including dermatology and women's health. To learn more about BioPharmX, visit www.BioPharmX.com.

BioPharmX is a registered trademark of BioPharmX, Inc.

 

Cision View original content:http://www.prnewswire.com/news-releases/biopharmx-cancels-presentation-at-oppenheimers-28th-annual-healthcare-conference-due-to-severe-weather-300617178.html

SOURCE BioPharmX Corporation

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store